Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.
Latest from Tom Gallen
Futura Medical is seeking OTC medical device approval for ED treatment Eroxon Intense, designed for men who prefer a stronger sensation to the original Eroxon product.
Stada is reviewing potential M&A for its Consumer Healthcare business, which last year grew its sales despite a weak cough & cold season.
A new oral health manufacturing site in Shanghai will help facilitate Haleon's push into China's tier 2 and 3 cities where the middle class population is rapidly expanding.
Karo has come to an agreement with the Norwegian Competition Authority to sell its Locobase skin care brand to allay competition concerns in the Nordic region.
Distribution deals helped Galenica grow its OTC sales in 2025 despite lower demand for cold and flu products.
A round-up of the latest European health & wellness people moves: Aboca hires Germany head; SkinBioTherapeutics gets interim CEO; Reckitt adds experience to board.